Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

UK's Chemring FY26 adjusted EBIT slightly misses; to sell US Sensors business

By Reuters News


Overview

  • UK defence technology group's FY26 adjusted EBIT slightly missed analyst expectations

  • Company reported record £1.4 bln order book and multiple strategic contract wins

  • Initiated sale process for US Sensors business after strategic review


Outlook

  • Chemring expects strong year-on-year earnings growth in FY27, supported by its order book

  • Company says FY27 underlying operating profit to be more evenly weighted between H1 and H2

  • Capacity expansion projects in Energetics expected to drive growth from 2027 and 2028


Result Drivers

  • RECORD ORDER BOOK - Co said strong demand across core markets led to a record £1.4 bln order book at year-end

  • CONTRACT AWARDS DELAYS - Roke’s FY26 performance was below expectations due to delays in defence contract awards, mainly from UK MOD and international customers

  • SEGMENT PERFORMANCE - Countermeasures & Energetics segment performed strongly, while Roke saw record order intake despite contract delays


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

FY Adjusted EBIT

Slight Miss*

GBP 79 mln

GBP 79.64 mln (7 Analysts)

FY Net Debt

GBP 145 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the aerospace & defense peer group is "buy."

  • Wall Street's median 12-month price target for Chemring Group PLC is GBp650.00, about 23.6% above its November 11 closing price of GBp526.00

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 25 three months ago


Reuters Recommended Reads

  • Nov 11 - Arms producer CSG cuts margin outlook on ammunition prices, shares slump

  • Nov 10 - UK's Avon Technologies FY26 adjusted profit beats estimates on strong demand, cost cuts

  • Nov 10 - Germany's Helsing to unveil AI-based military software as a rival to Palantir


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.